Saint Louis, MO – According to filings with the U.S. Securities and Exchange Commission, SentiAR is raising $5,597,974.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Berk Tas played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SentiAR SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, floating over the patient. The visualization is fully controllable hands-free by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission. through a holographic headset, the SentiAR platform offers a much richer perspective for clinicians. Our technology converts CT, MRI, and real-time mapping/catheter location outputs into a real-time hologram in the clinician field of view. Within the sterile field, the EP can expand, measure, or enter the chambers of the floating cardiac model for a significantly faster procedure with higher accuracy. The platform allows for visualization to multiple clinicians with multiple headsets.

To learn more about SentiAR, visit http://www.sentiar.com/

Contact:
Berk Tas, President and Chief Executive Officer
612-558-5673
https://www.linkedin.com/in/berk-tas-ab537722/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved